ZLDPF Dividend: Zealand Pharma A/S Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

ZLDPF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	9,155	62	342	103	108	192
Revenue Growth (YoY)	11,946%	-82%	231.99%	-5%	-44%	368%
Cost of Revenue	1	7	19	0	10	0
Gross Profit	9,153	54	323	103	97	192
Selling, General & Admin	558	397	190	263	293	212
Research & Development	1,328	900	666	590	561	581
Operating Expenses	1,886	1,323	884	879	879	794
Other Non Operating Income (Expenses)	-5	-6	-19	2	6	-4
Pretax Income	7,115	-1,083	-708	-972	-758	-673
Income Tax Expense	572	-4	-5	-6	-3	-4
Net Income	6,543	-1,078	-703	-1,202	-1,018	-846
Net Income Growth	-722%	53%	-42%	18%	20%	48%
Shares Outstanding (Diluted)	70.3	66.43	56.58	46.2	42.86	38.36
Shares Change (YoY)	-1%	17%	22%	8%	12%	14%
EPS (Diluted)	93.07	-16.23	-12.43	-26.02	-23.75	-22.06
EPS Growth	-725%	31%	-52%	10%	8%	30%
Free Cash Flow	7,372	-943	-449	-954	-1,234	-713
Free Cash Flow Per Share	104.86	-14.19	-7.93	-20.64	-28.78	-18.58
Gross Margin	99.97%	87.09%	94.44%	100%	89.81%	100%
Operating Margin	79.37%	-2,046.77%	-164.03%	-752.42%	-724.07%	-313.54%
Profit Margin	71.46%	-1,738.7%	-205.55%	-1,166.99%	-942.59%	-440.62%
Free Cash Flow Margin	80.52%	-1,520.96%	-131.28%	-926.21%	-1,142.59%	-371.35%
EBITDA	7,292	-1,244	-533	-748	-757	-560
EBITDA Margin	79.65%	-2,006.45%	-155.84%	-726.21%	-700.92%	-291.66%
D&A For EBITDA	25	25	28	27	25	42
EBIT	7,267	-1,269	-561	-775	-782	-602
EBIT Margin	79.37%	-2,046.77%	-164.03%	-752.42%	-724.07%	-313.54%
Effective Tax Rate	8.03%	0.36%	0.7%	0.61%	0.39%	0.59%